Melatonin deserves special attention because it is a safe nontoxic compound that has been shown to greatly improve the response of many different anti-cancer agents. Melatonin is a molecule that naturally occurs in the body and is primarily produced within the pineal gland. It is well accepted that melatonin is not only a hormone, but also a cell protector, involved in immunomodulation, antioxidative processes and cell growth regulation.
Experimental studies have proven that melatonin causes tumor growth inhibition in both in vitro and in vivo models. Melatonin by itself does not trigger cancer cell death but greatly enhances the effects of various cancer treatments while protecting normal cells. Melatonin can be safely incorporated into a cancer treatment plan while offering substantial benefits without any adverse side effects. Dosages are well above those administered as a sleep aid.
Scientific references are presented by clicking here.